01
Chemoinformatics
QSAR modelling, virtual screening and ligand-based design across million-compound spaces.
- Lead time
- 3–6 wks
- Stack
- RDKit · OEChem
Contract R&D · Drug Discovery
From target idea to pre-clinical candidate — in months, not decades.
Digital BioPharm is a full-stack contract research partner for pharma & biotech — now resuming operations. Computational chemistry, medicinal chemistry, synthesis, biology and analytics under one roof, reporting to pharma-grade standards.
Send the target and the stage you are at — a scientist, not a salesperson, replies within two business days.
01The Practice
Scientists first. A partner that ships, not a vendor that invoices.
01
About Us
Digital BioPharm is a contract research organisation built for modern drug discovery — a distributed team of chemists, biologists and engineers delivering programmes for pharma, biotech and academic groups. Founded by Dr. Andrey Voronkov in 2010.
See what we do02
Areas of Research
From computational hit finding to pre-clinical candidates: oncology, age-related and neurodegenerative disease, epigenetics and protein–ligand interactions — with cloud-scale cheminformatics behind every decision.
See the pipeline03
Our Mission
To compress the distance between a disease and its cure — making rigorous, transparent and fast research available to teams of every size, from first hypothesis to the molecule that reaches the clinic.
Start a programme02Capability Matrix
A full research stack, engineered like a spec sheet.
Nine integrated capabilities you can engage individually or as an end-to-end programme. Every line is scoped, timed and reported to pharma-grade standards.
02
Medicinal Chemistry
Hit-to-lead optimisation with a clear SAR roadmap and IP-aware design.
- Cycle
- 2–4 wks
- Scale
- mg → g
03
Organic Synthesis
Custom synthesis of building blocks, reference compounds and focused libraries.
- Purity
- ≥ 95%
- Report
- NMR · LC-MS
04
Biological Studies
In vitro assays, ADME profiling and target-engagement readouts.
- Panel
- 120+
- Format
- 384 / 1536
05
Analytical Chemistry
Structure elucidation, purity control and impurity profiling.
- Methods
- HPLC · NMR · HRMS
- Turnaround
- 5–10 days
05
Patent & IP Services
Freedom-to-operate analysis, prior-art search and patent drafting support.
- Coverage
- global
- Output
- FTO memo
07
IT & Programming
Secure research platforms, pipelines and custom cheminformatics tooling.
- Deploy
- cloud / on-prem
- Stack
- Python · k8s
08
Biomedical Animation
Mechanism-of-action visuals and molecular animations for publications & pitches.
- Format
- 4K · web
- Use
- MoA · grants
09
Case Examples
Selected delivered programmes — from target to pre-clinical candidate.
- Stage
- discovery → PCC
- Access
- on request
Need one of these — or all nine?
Tell us which stage you are at. We scope the work, name a price and a timeline before anything starts.
03Research Pipeline
Programmes in flight — open for collaboration.
Active internal and partnered programmes. Each line is a working target, not a slide.
DD@H
DrugDiscovery@Home
A distributed, cloud-native discovery platform connecting remote research teams to shared computational and wet-lab capacity.
TET
TET1–TET3 Small-Molecule Inhibitors
Design and optimisation of selective inhibitors of the TET family demethylases for epigenetic therapy.
AD
Alzheimer's Disease Programme
Multi-target lead discovery against aggregation and neuroinflammation pathways.
SCS
Stem Cell Signalling
Small-molecule modulators of stem-cell fate for regenerative and oncology applications.
AGE
Age-Related Diseases
Target identification and hit discovery across senescence and metabolic ageing axes.
PLI
Protein–Ligand Interactions
Biophysical evaluation, docking and validation of binding events at scale.
Want to run a programme with us?
Partnered programmes, contract work or a second opinion on someone else’s data — all three are on the table.
04Collaboration
Areas of primary interest.
We partner where our science is strongest. Bring a target, a hypothesis or a dataset — we'll bring the team.
- Cancer
- Age-related diseases
- Cloud computing in life sciences
- Stem cell signalling
- Alzheimer’s disease
- Protein–ligand interactions